These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 7594068)

  • 1. Adverse long-term effects of reocclusion after coronary thrombolysis.
    Brouwer MA; Böhncke JR; Veen G; Meijer A; van Eenige MJ; Verheugt FW
    J Am Coll Cardiol; 1995 Nov; 26(6):1440-4. PubMed ID: 7594068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction.
    Kievit PC; Brouwer MA; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2004 Nov; 148(5):826-33. PubMed ID: 15523313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.
    Brouwer MA; Kievit PC; Dieker HJ; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2008 Jun; 155(6):1039-46. PubMed ID: 18513517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
    van den Bergh PJ; Kievit PC; Brouwer MA; Aengevaeren WR; Veen G; Verheugt FW
    Am Heart J; 2009 Mar; 157(3):532-40. PubMed ID: 19249425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
    Brouwer MA; van den Bergh PJ; Aengevaeren WR; Veen G; Luijten HE; Hertzberger DP; van Boven AJ; Vromans RP; Uijen GJ; Verheugt FW
    Circulation; 2002 Aug; 106(6):659-65. PubMed ID: 12163424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling.
    Meijer A; Verheugt FW; van Eenige MJ; Werter CJ
    Circulation; 1994 Oct; 90(4):1706-14. PubMed ID: 7923654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial). Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis.
    Veen G; de Boer MJ; Zijlstra F; Verheugt FW
    Am J Cardiol; 1999 Oct; 84(7):763-7. PubMed ID: 10513770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.
    Meijer A; Verheugt FW; Werter CJ; Lie KI; van der Pol JM; van Eenige MJ
    Circulation; 1993 May; 87(5):1524-30. PubMed ID: 8491007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis.
    Veen G; Meyer A; Verheugt FW; Werter CJ; de Swart H; Lie KI; van der Pol JM; Michels HR; van Eenige MJ
    J Am Coll Cardiol; 1993 Dec; 22(7):1755-62. PubMed ID: 8245325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reocclusion: the flip side of coronary thrombolysis.
    Verheugt FW; Meijer A; Lagrand WK; Van Eenige MJ
    J Am Coll Cardiol; 1996 Mar; 27(4):766-73. PubMed ID: 8613601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thallium-dipyridamole in acute myocardial infarction treated by thrombolysis: diagnostic and prognostic value].
    D'Urbano M; Cafiero F; Cammelli F; Spreafico GL; Romano S
    G Ital Cardiol; 1994 Jan; 24(1):11-20. PubMed ID: 8200491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term implications of reocclusion on left ventricular size and function after successful thrombolysis for first anterior myocardial infarction.
    Nijland F; Kamp O; Verheugt FW; Veen G; Visser CA
    Circulation; 1997 Jan; 95(1):111-7. PubMed ID: 8994425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
    White HD; French JK; Hamer AW; Brown MA; Williams BF; Ormiston JA; Cross DB
    J Am Coll Cardiol; 1995 Jan; 25(1):218-23. PubMed ID: 7798505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. The Flurbiprofen French Trial.
    Brochier ML
    Eur Heart J; 1993 Jul; 14(7):951-7. PubMed ID: 8375421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent.
    Loubeyre C; Lefèvre T; Louvard Y; Dumas P; Piéchaud JF; Lanore JJ; Angellier JF; Le Tarnec JY; Karrillon G; Margenet A; Pougès C; Morice MC
    Eur Heart J; 2001 Jul; 22(13):1128-35. PubMed ID: 11428853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The smoker's paradox after successful fibrinolysis: reduced risk of reocclusion but no improved long-term cardiac outcome.
    Kievit PC; Brouwer MA; Veen G; Aengevaeren WR; Verheugt FW
    J Thromb Thrombolysis; 2009 May; 27(4):385-93. PubMed ID: 18581058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prediction and prevention of reocclusion after coronary thrombolysis for acute myocardial infarction based on analysis of the coronary morphology with angiography].
    Ishihara M; Sato H; Tateishi H; Uchida T; Dote K
    J Cardiol; 1991; 21(3):625-30. PubMed ID: 1843513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mechanical recanalization of occluded coronary arteries without prior thrombolytic therapy in patients with acute myocardial infarction. A single-center study reporting acute results and complications.
    Emmerich K; Ulbricht LJ; Probst H; Krakau I; Hoffmeister T; Lürken E; Thale J; Gülker H
    Z Kardiol; 1995; 84 Suppl 2():5-23. PubMed ID: 7571783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse relation between diastolic blood pressure and long-term outcomes in patients undergoing pharmacoinvasive therapy for myocardial infarction: the J-shaped relation in the contemporary era of revascularisation.
    Lee CH; Foo D; Wong HB; Hong EC; Seow SC; Ng KS; Lim YT; Tan HC
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):806-11. PubMed ID: 17060806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognosis of patency of infarct-related coronary artery after thrombolytic treatment in acute myocardial infarction. Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Mar; 110(3):191-4. PubMed ID: 9594338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.